Reduced-intensity and myeloablative conditioning allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia and myelodysplastic syndrome: a meta-ana...

Por Zeng, Wen, Huang, Lifang, Meng, Fankai, Liu, Zeming, Zhou, Jianfeng, Sun, Hanying
Publicado no Int J Clin Exp Med (2014)

In vitro effects of imatinib on CD34(+) cells of patients with chronic myeloid leukemia in the megakaryocytic crisis phase

Por MENG, FANKAI, ZENG, WEN, HUANG, LIFANG, QIN, SHUANG, MIAO, NINGNING, SUN, HANYING, LI, CHUNRUI
Publicado em 2014

Chronic myeloid leukemia with variation of translocation at (Ph) [ins (22;9) (q11;q21q34)]: a case report

Por Wang, Zhiqiong, Zen, Wen, Meng, Fankai, Xin, Xing, Luo, Li, Sun, Hanying, Zhou, Jianfeng, Huang, Lifang
Publicado no Int J Clin Exp Pathol (2015)

Acute promyelocytic leukemia with cryptic t(15;17) on isochromosome 17: a case report and review of literature

Por Tang, Yuting, Wang, Ying, Hu, Liang, Meng, Fankai, Xu, Danmei, Wan, Kai, Huang, Lifang, Li, Chunrui, Zhou, Jianfeng
Publicado no Int J Clin Exp Pathol (2015)

Nuclear C-MYC expression level is associated with disease progression and potentially predictive of two year overall survival in prostate cancer

Por Zeng, Wen, Sun, Hanying, Meng, Fankai, Liu, Zeming, Xiong, Jing, Zhou, Sheng, Li, Fan, Hu, Jia, Hu, Zhiquan, Liu, Zheng
Publicado no Int J Clin Exp Pathol (2015)

Analysis of prognostic factors in lymphoma patients with bone marrow involvement: a single center cohort study

Por Xin, Xing, Liu, Zhaojun, Meng, Fankai, Zeng, Wen, Tian, Ming, Miao, Ningning, Wei, Jia, Sun, Hanying, Zhou, Jianfeng, Huang, Lifang
Publicado no Int J Clin Exp Med (2015)

Saline is a more appropriate solution for microvesicles for flow cytometric analyses

Por Xin, Xing, Zhang, Peiling, Fu, Xing, Mao, Xia, Meng, Fankai, Tian, Ming, Zhu, Xiaojian, Sun, Hanying, Meng, Li, Zhou, Jianfeng
Publicado no Oncotarget (2017)

Bortezomib-based chemotherapy regimens can improve response in newly diagnosed multiple myeloma patients with bcl-2 and survivin overexpression

Por Zeng, Wen, Meng, Fankai, Liu, Zeming, Mao, Xia, Luo, Li, Zheng, Miao, Qin, Shuang, Liu, Wenli, Zhou, Jianfeng, Sun, Hanying, Huang, Lifang
Publicado em 2014